Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1154

  • Unknown sort schema '{last_sort_schema}' ignored
  • The following term was not found in PubMed: F%5BAuthor%5D.
1.

Mechanical Properties of Gas Main Steels after Long-Term Operation and Peculiarities of Their Fracture Surface Morphology.

Hutsaylyuk V, Maruschak P, Konovalenko I, Panin S, Bishchak R, Chausov M.

Materials (Basel). 2019 Feb 5;12(3). pii: E491. doi: 10.3390/ma12030491.

PMID:
30764509
2.

A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.

Ideno N, Yamaguchi H, Okumura T, Huang J, Brun MJ, Ho ML, Suh J, Gupta S, Maitra A, Ghosh B.

Lab Invest. 2019 Feb 6. doi: 10.1038/s41374-018-0171-z. [Epub ahead of print]

PMID:
30728464
3.

A case of high-grade pancreatic intraepithelial neoplasia concomitant with type 1 autoimmune pancreatitis: the process underlying both conditions.

Sugiyama T, Tajiri T, Hiraiwa S, Machida T, Ito H, Yoshii H, Izumi H, Nomura E, Mukai M, Nakamura N.

Pathol Int. 2019 Feb 5. doi: 10.1111/pin.12768. [Epub ahead of print]

PMID:
30719801
4.

Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.

Nishikawa Y, Kodama Y, Shiokawa M, Matsumori T, Marui S, Kuriyama K, Kuwada T, Sogabe Y, Kakiuchi N, Tomono T, Mima A, Morita T, Ueda T, Tsuda M, Yamauchi Y, Sakuma Y, Ota Y, Maruno T, Uza N, Uesugi M, Kageyama R, Chiba T, Seno H.

Oncogene. 2019 Jan 31. doi: 10.1038/s41388-019-0718-5. [Epub ahead of print]

PMID:
30705405
5.

Pomalidomide alters pancreatic macrophage populations to generate an immune-responsive environment at precancerous and cancerous lesions.

Bastea LI, Liou GY, Pandey V, Fleming AK, Von Roemeling CA, Doeppler H, Li Z, Qiu Y, Edenfield B, Copland JA, Tun HW, Storz P.

Cancer Res. 2019 Jan 29. pii: canres.1153.2018. doi: 10.1158/0008-5472.CAN-18-1153. [Epub ahead of print]

PMID:
30696657
6.

Data-driven voluntary body motion detection and non-rigid event-by-event correction for static and dynamic PET.

Lu Y, Gallezot JD, Naganawa M, Ren S, Fontaine K, Wu J, Onofrey JA, Toyonaga T, Boutagy NE, Mulnix T, Panin VY, Casey ME, Carson RE, Liu C.

Phys Med Biol. 2019 Jan 29. doi: 10.1088/1361-6560/ab02c2. [Epub ahead of print]

PMID:
30695768
7.

BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis.

Das S, Bar-Sagi D.

Oncogene. 2019 Jan 11. doi: 10.1038/s41388-018-0668-3. [Epub ahead of print]

PMID:
30635655
8.

Circumventing senescence is associated with stem cell properties and metformin sensitivity.

Deschênes-Simard X, Parisotto M, Rowell MC, Le Calvé B, Igelmann S, Moineau-Vallée K, Saint-Germain E, Kalegari P, Bourdeau V, Kottakis F, Bardeesy N, Ferbeyre G.

Aging Cell. 2019 Jan 6:e12889. doi: 10.1111/acel.12889. [Epub ahead of print]

9.

Zebrafish model of KRAS-initiated pancreatic cancer.

Park JT, Leach SD.

Anim Cells Syst (Seoul). 2018 Oct 8;22(6):353-359. doi: 10.1080/19768354.2018.1530301. eCollection 2018.

10.

[Perforated duodenal ulcer in high risk patients].

Beburishvili AG, Panin SI, Mikhailov DV, Postolov MP.

Khirurgiia (Mosk). 2018;(11):39-43. doi: 10.17116/hirurgia201811139. Russian.

PMID:
30531752
11.

[ONSTEP procedure for inguinal hernia repair].

Smirnov AV, Petrov DY, Panin AV, Dubrovsky AV, Nemkova AI.

Khirurgiia (Mosk). 2018;(10):12-17. doi: 10.17116/hirurgia201810112. Russian.

PMID:
30531730
12.

RET, a targetable driver of pancreatic adenocarcinoma.

Amit M, Na'ara S, Fridman E, Vladovski E, Wasserman T, Milman N, Gil Z.

Int J Cancer. 2018 Dec 4. doi: 10.1002/ijc.32040. [Epub ahead of print]

PMID:
30515799
13.

The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice.

Young CC, Baker RM, Howlett CJ, Hryciw T, Herman JE, Higgs D, Gibbons R, Crawford H, Brown A, Pin CL.

Cell Mol Gastroenterol Hepatol. 2018 Sep 14;7(1):93-113. doi: 10.1016/j.jcmgh.2018.09.004. eCollection 2019.

14.

miRNA-1290 Promotes Aggressiveness in Pancreatic Ductal Adenocarcinoma by Targeting IKK1.

Ta N, Huang X, Zheng K, Zhang Y, Gao Y, Deng L, Zhang B, Jiang H, Zheng J.

Cell Physiol Biochem. 2018;51(2):711-728. doi: 10.1159/000495328. Epub 2018 Nov 21.

15.

HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival.

Yan H, Qiu W, Koehne de Gonzalez AK, Wei JS, Tu M, Xi CH, Yang YR, Peng YP, Tsai WY, Remotti HE, Miao Y, Su GH.

Cancer Lett. 2019 Feb 1;442:333-340. doi: 10.1016/j.canlet.2018.11.007. Epub 2018 Nov 14.

PMID:
30447255
16.

Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma.

Thakkar A, Desai P, Chenreddy S, Modi J, Thio A, Khamas W, Ann D, Wang J, Prabhu S.

Am J Cancer Res. 2018 Oct 1;8(10):2005-2019. eCollection 2018.

17.

Pancreatic Acinar-to-Ductal Metaplasia and Pancreatic Cancer.

Wang L, Xie D, Wei D.

Methods Mol Biol. 2019;1882:299-308. doi: 10.1007/978-1-4939-8879-2_26.

PMID:
30378064
18.

Induction of Pancreatic Inflammation Accelerates Pancreatic Tumorigenesis in Mice.

Zhuang L, Zhan X, Bi Y, Ji B.

Methods Mol Biol. 2019;1882:287-297. doi: 10.1007/978-1-4939-8879-2_25.

PMID:
30378063
19.

Spheroid Culture of Human Pancreatic Ductal Cells to Reconstitute Development of Pancreatic Intraepithelial Neoplasia.

Lee JJ, Kim SK.

Methods Mol Biol. 2019;1882:63-71. doi: 10.1007/978-1-4939-8879-2_6.

PMID:
30378044
20.

Generation of Induced Pluripotent Stem Cell-Like Lines from Human Pancreatic Ductal Adenocarcinoma.

Kim J, Zaret KS.

Methods Mol Biol. 2019;1882:33-53. doi: 10.1007/978-1-4939-8879-2_4.

PMID:
30378042

Supplemental Content

Loading ...
Support Center